Skip to content

Home
Insights
Brochures
Careers
About us
News

Home
Insights
Brochures
Careers
About us
News

Author name: YASHASWINI N

Highlights from the week of 22nd June - 29th June Gilead Sciences ( FDA, EU, Approval ) FDA and EC grant approval to Gilead's TRODELVY for the treatment of adults with unresectable, locally advanced, mTNBC Merck ( FDA, Approval ) FDA approves Merck's KEYTRUDA and KEYTRUDA QLEX, each in combination with TRODELVY, for the first-line treatment of adults with unresectable, locally advanced, or metastatic TNBC AbbVie ( EU, Approval ) AbbVie's MAVIRET obtains EC approval to treat acute HCV infection in those aged 3 years and older AstraZeneca ( EU, Approval ) EC provides approval to AstraZeneca and Daiichi Sankyo's ENHERTU as monotherapy to treat adults with unresectable or metastatic HER2-positive IHC3+ solid tumours All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 22nd June – 29th June in the world of pharma and healthcare!

Uncategorized / YASHASWINI N

Highlights from the Week of 22nd June – 29th June in the world of pharma and healthcare! Read More »

Highlights from the Week of 15th June 2026 - 22nd June 2026 ( FDA, Approval ) Merck's CAPVAXIVE gets FDA approval for an expanded indication that includes those aged 12-17 years with an increased pneumococcal disease risk ( FDA, Approval ) AbbVie's Allergan Aesthetics receives FDA approval for SKINVIVE by JUVÉDERM to reduce neck lines in adults over the age of 21 ( FDA, Approval ) FDA approves GSK and Spero Therapeutics' UTEBZI for the treatment of cUTIs, including pyelonephritis, in adults with limited or no alternative oral options ( EU, Approval ) EC gives centralized marketing authorization to CinnaGen's ZANDORIAH, a biosimilar for the treatment of osteoporosis in adults Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 15th June – 22nd June in the world of pharma and healthcare!

Uncategorized / YASHASWINI N

Highlights from the Week of 15th June – 22nd June in the world of pharma and healthcare! Read More »

J P Morgan European Healthcare Forum June 18 2026 June 18 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of June 18,2026

Uncategorized / YASHASWINI N

Attention stay up to date with the latest investor calls by checking out our calendar for the week of June 18,2026 Read More »

Highlights from the week of 08th June - 15th June Sanofi ( FDA, Approval ) Sanofi's Tzield gets FDA approval to treat patients recently diagnosed with Stage 3 type 1 diabetes Eli Lilly ( FDA, Approval ) FDA grants approval to Eli Lilly's EBGLYSS 250 mg/2 mL SC injection for maintenance dosing to treat moderate-to-severe atopic dermatitis AstraZeneca ( FDA, Approval ) AstraZeneca's TRUQAP, in combination with abiraterone and prednisone, gains FDA approval to treat adults with mAPMN/S prostate cancer Novo Nordisk ( UK, Approval ) MHRA grants approval to Novo Nordisk's WEGOVY as an injectable treatment adjunct to a reduced-calorie diet and increased physical activity for obesity All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 08th June – 15th June in the world of pharma and healthcare!

Uncategorized / YASHASWINI N

Highlights from the Week of 08th June – 15th June in the world of pharma and healthcare! Read More »

Goldman Sachs 47th Annual Global Healthcare Conference June 08,2026 To June 10,2026 June 08 June 09 June 10 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of June 08,2026 To June 10,2026

Uncategorized / YASHASWINI N

Attention stay up to date with the latest investor calls by checking out our calendar for the week of June 08,2026 To June 10,2026 Read More »

Highlights from the Week of 01st June 2026 - 08th June 2026 ( EU, Approval ) EC grants approval to Sanofi's SARCLISA SC in combination with standard-of-care regimens for the treatment of patients with multiple myeloma ( FDA, Orphan Drug, Fast Track ) TearSolutions' LACRIPEP received Orphan Drug and Fast Track designations from the FDA to treat neurotrophic keratitis ( FDA, Fast Track ) FDA grants Fast Track designation to Merakris Therapeutics' MTX-001 that treats venous leg ulcers ( FDA, Fast Track ) FDA provides Fast Track designation to Verastem Oncology's VS-7375 for the treatment of adult patients with KRAS G12D-mutated unresectable locally advanced or metastatic NSCLC Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 01st June – 08th June in the world of pharma and healthcare!

Uncategorized / YASHASWINI N

Highlights from the Week of 01st June – 08th June in the world of pharma and healthcare! Read More »

INVESTOR CALENDER OF THE WEEK June 01,2026 To June 04,2026 Investor Event at ASCO 2026 June 01 June 02 Jefferies Global Healthcare Conference June 03 June 04

Attention stay up to date with the latest investor calls by checking out our calendar for the week of June 01,2026 To June 04,2026

Uncategorized / YASHASWINI N

Attention stay up to date with the latest investor calls by checking out our calendar for the week of June 01,2026 To June 04,2026 Read More »

Highlights from the week of 25th May - 01st June AbbVie ( FDA, Approval ) AbbVie's DECNUPAZ gains FDA approval to treat BPDCN, a hematologic malignancy with limited treatment options AstraZeneca ( FDA, Approval ) FDA gives approval to AstraZeneca's IMFINZI in combination with BCG induction and maintenance therapy for the treatment of adult patients with BCG-naïve, high-risk NMIBC Shionogi ( FDA, Approval ) Shionogi's XOCOVA receives FDA approval for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years and older Mannkind ( FDA, Approval ) MannKind's AFREZZA inhalation powder is now FDA approved for use in children and adolescents aged 6 years and older with type 1 and 2 diabetes All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 25th May – 01st June in the world of pharma and healthcare!

Uncategorized / YASHASWINI N

Highlights from the Week of 25th May – 01st June in the world of pharma and healthcare! Read More »

Bernstein’s 42nd Annual Strategic Decisions Conference May 27,2026 To May 29,2026 May 27 May 28 May 29 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 27,2026 To May 29,2026

Uncategorized / YASHASWINI N

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 27,2026 To May 29,2026 Read More »

Highlights from the Week of 18th May 2026 - 25th May 2026 ( FDA, Approval ) AstraZeneca and Daiichi Sankyo gets FDA approval for its DATROWAY to treat adults with unresectable or metastatic TNBC ( FDA, Approval ) FDA approves AstraZeneca's BAXFENDY, an aldosterone synthase inhibitor, for the treatment of hypertension in combination with other antihypertensives ( FDA, Approval ) Bio-Thera and Accord BioPharma gets FDA approval for IMMGOLIS and IMMGOLIS INTRI, a biosimilar for the treatment of adults with moderately to severely active rheumatoid arthritis and ulcerative colitis ( CHMP, Positive Opinion ) Merck gets positive CHMP opinion for KEYTRUDA in combination with PADCEV as neoadjuvant treatment and as adjuvant treatment post radical cystectomy for adults with resectable MIBC Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 18th May – 25th May in the world of pharma and healthcare!

Uncategorized / YASHASWINI N

Highlights from the Week of 18th May – 25th May in the world of pharma and healthcare! Read More »

1 2 … 14 Next →

Search

Recent Posts

Highlights from the Week of 22nd June – 29th June in the world of pharma and healthcare!
Highlights from the Week of 15th June – 22nd June in the world of pharma and healthcare!
Today, June 21, is World ALS Day. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, impairing a person’s ability to move, speak, and breathe. Raising awareness isn’t just about acknowledging the disease; it’s about advocating for better care, funding critical research, and fostering inclusive communities. Let’s use our platforms today to amplify the voices of those living with ALS/MND and support the scientists working tirelessly toward a cure. 💡
Shining a light on World Sickle Cell Day. Today, we stand in solidarity with the millions of individuals globally managing sickle cell disease. Raising awareness is just the first step—driving equitable access to healthcare, advancing clinical research, and fostering inclusive environments are where real change happens. Let’s commit to being a part of the solution. 🩸❤️
Today, our team stands in solidarity with the global community on World Kidney Cancer Day. Renal Cell Carcinoma (RCC) impacts hundreds of thousands of families worldwide every year.”Awareness is the first line of defense. By amplifying the conversation around Renal Cell Carcinoma, we empower individuals to take charge of their health before it’s too late.”This year, our emphasis is on supporting the emotional well-being of patients and caregivers bearing the psychological burden of this disease. Let’s break the silence, encourage proactive health check-ups, and foster a more supportive environment for everyone affected by kidney cancer.🧡 Check in on your loved ones, prioritize your metabolic health, and let’s spread awareness together.

Recent Comments

No comments to show.

Archives

June 2026
May 2026
April 2026
March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025
February 2025
January 2025

Categories

Uncategorized

The Pharma BI division of

Vyuhgenics Inc.

Henderson, Nevada, USA – 89014

Vyuhpharma ®, All Rights Reserved.

Sitemap

Terms of use

Connect with us

Please fill in the information below, and we'll get back to you.

Full Name

Email Address

Your Company

Contact

Your message